• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Qlife Holding

1.97 SEK

-3.29 %

Less than 1K followers

QLIFE

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-3.29 %
+2.82 %
-2.57 %
-30.19 %
-33.47 %
-30.68 %
-95.98 %
-99.98 %
-99.92 %

Qlife Holding AB is a med-tech group that strives to revolutionize the market for clinical biomarkers and virus tests. By enabling tests at home as a complement to tests in healthcare, access to important health information is facilitated, which can contribute to better treatment and potentially prevent diseases. The first capsules in the company's product, Egoo.Health Platform, were CE-marked for professional use in early 2020. The company has patent protection for key parts of its technology. The Danish-based company is listed on Nasdaq First North Stockholm.

Read more
Market cap
56.82M SEK
Turnover
94.92K SEK
Revenue
320K
EBIT %
-6,056.25 %
P/E
-
Dividend yield-%
-
Coverage
Disclaimer
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Research
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
26.8
2026

Interim report Q2'26

11.11
2026

Interim report Q3'26

10.2
2027

Annual report '26

Regulatory press release6/1/2026, 7:00 AM

Qlife Holding AB: Qlife enters fully funded feasibility agreement with global pharma company for Egoo Health biomarker application

Qlife Holding
Regulatory press release5/27/2026, 10:01 AM

Bulletin from the Annual General Meeting 2026 of Qlife Holding AB

Qlife Holding
Regulatory press release5/13/2026, 6:30 AM

QLIFE HOLDING AB, Interim Report Q1, January - March 2026

Qlife Holding

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/24/2026, 6:30 AM

Qlife Holding AB publishes Annual Report for 2025

Qlife Holding
Regulatory press release4/23/2026, 1:21 PM

Notice of the 2026 Annual General Meeting of Qlife Holding AB

Qlife Holding
Regulatory press release4/23/2026, 1:17 PM

Qlife Holding AB: The ISP leaves notifications under the FDI Act without action in connection with allotment to certain investors in Qlife's rights issue

Qlife Holding
Regulatory press release4/1/2026, 4:33 PM

Qlife Holding AB: Qlife announces the last day of trading in BTA

Qlife Holding
Regulatory press release3/24/2026, 7:30 AM

Qlife Holding AB: Qlife announces the outcome of the rights issue and resolves on a directed issue of shares to guarantors

Qlife Holding
Press release3/17/2026, 8:00 AM

Qlife Holding AB: Qlife provides business update on clinical progress, partnerships and commercialization initiatives

Qlife Holding
Regulatory press release3/17/2026, 7:45 AM

Qlife Holding AB: The subscription period in Qlife's rights issue ends on Thursday, 19 March 2026

Qlife Holding
Press release3/13/2026, 7:30 AM

Qlife Holding AB: Hipro to accelerate Egoo development and regulatory approval in China following strong interest

Qlife Holding
Regulatory press release3/5/2026, 7:50 AM

Qlife Holding AB: The subscription period in Qlife's rights issue begins today

Qlife Holding
Regulatory press release3/4/2026, 7:40 AM

Qlife Holding AB: Qlife publishes information document due to upcoming rights issue

Qlife Holding
Regulatory press release2/27/2026, 5:20 PM

Qlife Holding AB: Qlife announces that two investors have entered agreements to subscribe for shares if the rights issue is subscribed below approx. 51.0 percent, taking over commitments from a group of guarantors

Qlife Holding
Regulatory press release2/26/2026, 10:05 AM

Bulletin from Extraordinary General Meeting 2026 of Qlife Holding AB

Qlife Holding
Press release2/25/2026, 7:30 AM

Qlife Holding AB: Qlife launches pharmacy pilot project in Nordic markets

Qlife Holding
Regulatory press release2/19/2026, 5:03 PM

Qlife Holding AB: Guarantor converts guarantee commitment of SEK 0.5 million into binding subscription commitment and top guarantor waives guarantee compensation in Qlife's ongoing rights issue

Qlife Holding
Regulatory press release2/11/2026, 7:30 AM

Qlife Holding AB: QLIFE HOLDING AB, Interim Report Q4, October - December 2025

Qlife Holding
Regulatory press release1/26/2026, 9:56 AM

Notice of Extraordinary General Meeting 2026 in Qlife Holding AB

Qlife Holding
Regulatory press release1/26/2026, 7:30 AM

Qlife Holding AB: Qlife submits Egoo PHE home testing system for regulatory approval

Qlife Holding